Society for Immunotherapy of Cancer
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.
Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere.
Currently, SITC has more than 1,700 members representing 17 medical specialties and are engaged in research and treatment of at least a dozen types of cancer.
Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word “cure” a reality for cancer patients everywhere.
Currently, SITC has more than 1,700 members representing 17 medical specialties and are engaged in research and treatment of at least a dozen types of cancer.
info@sitcancer.org 1 414 271 2456
